Preliminary outcome of Prostatype Genomics AB share issue
Prostatype Genomics AB ("Prostatype Genomics" or "Company") today announces the preliminary outcome of the preferential share issue for the shareholders (the "Preferential Share Issue") which was completed today. The preliminary subscription summary shows that approximately 56.3 percent subscribed with and without the support of subscription rights. The Preferential Share Issue was guaranteed to approximately 70 percent through guarantee commitments, and thus the Company will receive approximately MSEK 24.0 before issue costs.THIS PRESS RELEASE MAY NOT BE DISCLOSED, PUBLISHED OR DISTRIBUTED,